At Centrum Pharmacy, we are always monitoring global events that may affect the accessibility and affordability of your medications. A recent development out of the United States could have long-term implications for Canada’s pharmaceutical landscape—and ultimately, for Canadian patients.
U.S. Proposes Major Tariffs on Canadian Drug Exports
Earlier this month, the U.S. government signaled it may impose pharmaceutical tariffs of up to 200% on medications exported from Canada. While no official policy has been enacted yet, this announcement has already sent shockwaves through the pharmaceutical industry, especially in provinces like Manitoba where medicine manufacturing is a major economic driver.
“If a 200 per cent tariff were to be put into place, then [drug manufacturers] would have to reconsider whether it makes sense to manufacture in Canada,” said Shawn Bugden, Dean of Pharmacy at Memorial University.
What Does This Mean for Canadian Patients?
While the full impact of these potential tariffs is still uncertain, experts agree the situation is complex. Canada already imports 70% of its medications, including 16% from the U.S., worth nearly $9 billion. Any disruptions in trade—whether from tariffs or retaliatory measures—could affect both drug pricing and availability.
Risks to Canadian Drug Supply Security
If U.S. tariffs make it more expensive to export pharmaceuticals from Canada, companies may shift manufacturing out of the country entirely. This could weaken Canada’s drug supply chain and reduce our ability to manage shortages—something many of us experienced firsthand during the COVID-19 pandemic.
Canada’s Drug Price Control System Under Pressure
A lesser-known but important consequence of such tariffs could be pressure on Canada’s drug price regulation system—namely the Patented Medicine Prices Review Board (PMPRB) and the pan-Canadian Pharmaceutical Alliance. These institutions keep drug prices lower in Canada by setting limits and negotiating pricing with manufacturers.
But if global drug production costs rise due to tariffs, Canadian regulators may find it harder to enforce price caps, especially for life-saving medications. This could lead to higher prices for patients—or reduced access if companies choose not to launch their products here.
What Can Canadians Do?
Fortunately, there’s no need to panic or stockpile your medications. As Bugden says, “I don’t think consumers need to worry about the prices changing tomorrow. Keep calm and carry on.”
At Centrum Pharmacy, we are committed to:
- Monitoring developments and adjusting procurement strategies if needed
- Working closely with prescribers to offer therapeutic alternatives when necessary
- Advocating for patients and ensuring access to affordable medication remains a priority
We’ll keep you informed as this situation evolves. In the meantime, if you have concerns about your prescriptions or the cost of your medication, our pharmacists are always here to help.
Stay Connected with Centrum Pharmacy!
If you found this article helpful, don’t forget to like, share, and Follow to stay up to date on our latest health tips, pharmacy updates, and wellness advice.
Come for the Convenience, Stay for the Service.
Caring for Your Family Since 1999
Disclaimer: The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your healthcare provider first. Full Disclaimer.
